Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

ClinicalTrials.gov ID: NCT00237536

Public ClinicalTrials.gov record NCT00237536. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 11:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Dose Comparison Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to evaluate the dose response relationship of lonidamine and the primary efficacy endpoint, International Prostate Symptom Score (IPSS), in subjects with symptomatic benign prostatic hyperplasia (BPH).

Study identification

NCT ID
NCT00237536
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Threshold Pharmaceuticals
Industry
Enrollment
240 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
65 Years to 80 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2005 (Type not available)
Primary completion
Aug 2006 (Actual)
Completion
Aug 2006 (Actual)
Last update posted
Apr 29, 2009

2005 – 2006

United States locations

U.S. sites
34
U.S. states
17
U.S. cities
32
Facility City State ZIP Site status
Advanced Clinical Therapeutics Tucson Arizona 85712 —
Chris B. Threatt, MD Inc. Atherton California 94027 —
Urological Sciences Research Foundation Culver City California 90232 —
Atlantic Urological Medical Group Long Beach California 90806 —
California Professional Research Newport Beach California 92660 —
San Diego Uro-Research San Diego California 92103 —
Stanford University Hospital Stanford California 94305 —
Urology Research Options Aurora Colorado 80012 —
Connecticut Clinical Research Center Urology Specialists Waterbury Connecticut 06708 —
South Florida Medical Research Aventura Florida 33180 —
Tampa Bay Medical Research Clearwater Florida 33761 —
Florida Healthcare Research Ocala Florida 34474 —
Midwest Prostate & Urology Health Center Chicago Illinois 60640 —
Specialty Care Research Peoria Illinois 61614 —
Northeast Indiana research, LLC Fort Wayne Indiana 46825 —
Metropolitan Urology Jeffersonville Indiana 47130 —
Werner, Murdock & Francis, PA, Urology Associates Greenbelt Maryland 20770 —
Sheldon J. Freedman, MD Ltd. Las Vegas Nevada 89109 —
Delaware Valley Clinical Research Cherry Hill New Jersey 08003 —
Lawrenceville Urology Lawrenceville New Jersey 08648 —
Urology Healthcare Associates Woodlane New Jersey 08060 —
Accumed Research Associates Garden City New York 11530 —
New York University School of Medicine New York New York 10016 —
Weill Medical College of Cornell University New York New York 10021 —
Radiant Research. Columbus Columbus Ohio 43212 —
Urological Associates of Lancaster Lancaster Pennsylvania 17604 —
State College Urologic Associates State College Pennsylvania 16801 —
University Urological Research Institute Providence Rhode Island 02904 —
Radiant Research, Greer Greer South Carolina 29651 —
UT Southwestern Medical Center at Dallas, Dept of Urology Dallas Texas 75390 —
Accelovance Houston Texas 77024 —
Baylor College of Medicine, Scott Department of Urology Houston Texas 77030 —
Urology San Antonio Research San Antonio Texas 78229 —
Integrity Medical Research, LLC Mountlake Terrace Washington 98043 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00237536, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 29, 2009 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00237536 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →